HomeZYUS • CVE
add
ZYUS Life Sciences Corp
Previous close
$0.90
Day range
$0.82 - $0.94
Year range
$0.70 - $1.19
Market cap
60.97M CAD
Avg Volume
2.79K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 123.00K | 24.24% |
Operating expense | 3.73M | -5.52% |
Net income | -3.92M | 6.56% |
Net profit margin | -3.19K | 24.79% |
Earnings per share | -0.05 | 16.67% |
EBITDA | -2.94M | 7.40% |
Effective tax rate | 0.43% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 346.00K | -96.20% |
Total assets | 33.98M | -52.70% |
Total liabilities | 19.09M | -23.93% |
Total equity | 14.89M | — |
Shares outstanding | 74.36M | — |
Price to book | 4.50 | — |
Return on assets | -26.23% | — |
Return on capital | -37.72% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -3.92M | 6.56% |
Cash from operations | -1.50M | 82.63% |
Cash from investing | -11.00K | 68.57% |
Cash from financing | 1.02M | 284.39% |
Net change in cash | -490.00K | 94.67% |
Free cash flow | -21.25K | 99.66% |
About
Founded
2018
Headquarters
Website
Employees
2
